A detailed history of 626 Financial, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, 626 Financial, LLC holds 1,087 shares of ZTS stock, worth $192,116. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,087
Holding current value
$192,116
% of portfolio
0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$172.58 - $196.48 $187,594 - $213,573
1,087 New
1,087 $212,000
Q3 2023

Oct 11, 2023

BUY
$167.14 - $192.77 $216,446 - $249,637
1,295 New
1,295 $225,000
Q1 2023

Apr 12, 2023

BUY
$145.48 - $175.02 $188,396 - $226,650
1,295 New
1,295 $215,000
Q1 2021

Apr 14, 2022

BUY
$144.0 - $169.39 $186,480 - $219,360
1,295 New
1,295 $244,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track 626 Financial, LLC Portfolio

Follow 626 Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 626 Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 626 Financial, LLC with notifications on news.